Skip to main content
Veterinary Medicines

TRESADERM soluzione oto-dermatologica per cani e gatti

Authorised
  • Dexamethasone
  • NEOMYCIN SULFATE
  • Tiabendazole

Product identification

Medicine name:
TRESADERM soluzione oto-dermatologica per cani e gatti
Active substance:
  • Dexamethasone
  • NEOMYCIN SULFATE
  • Tiabendazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use
  • Cutaneous use

Product details

Active substance and strength:
  • Dexamethasone
    1.00
    gram(s)
    /
    1.00
    millilitre(s)
  • NEOMYCIN SULFATE
    0.32
    gram(s)
    /
    1.00
    millilitre(s)
  • Tiabendazole
    4.00
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, solution
Withdrawal period by route of administration:
  • Auricular use
    • Dog
      • Unspecified
        0
        day
    • Cat
      • Unspecified
        0
        day
  • Cutaneous use
    • Dog
      • Unspecified
        0
        day
    • Cat
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07CB
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme B.V.
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 30/03/2023